Article Details
Retrieved on: 2022-03-02 05:20:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE:PFE) today announced results from the CLOVER trial (CLOstridium difficile Vaccine Efficacy TR ...
Article found on: www.pfizer.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here